{"generated":"2026-10-08T11:36:03Z","content_changed":"2026-10-07T04:17:06Z","window_days":30,"count":225,"note":"Elke wijziging in de Lemmid Manager achter hartvaat.nl in de laatste 30 dagen; vergelijk updated met je vorige bezoek en herlees alleen wat veranderde.","changes":[{"updated":"2026-10-07T04:17:06Z","type":"podcastepisode","id":"79993","title":"#53: De dood op recept - hoe werkt euthanasie?","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-10-07T04:17:06Z","type":"podcastepisode","id":"79994","title":"Spreekuur Extra: waar zijn de anti-rookcampagnes gebleven?","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-10-07T04:17:05Z","type":"podcastepisode","id":"79992","title":"Journal editorial: Not all asymmetry is equal: asymmetric septal hypertrophy across hypertrophic cardiomyopathy, amyloidosis and beyond","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"0d05770d5f8a","title":"Polikliniekmedewerker Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"168876ba4018","title":"Interventielaborant Hartcatheterisatiekamer - In Opleiding","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"eaf60ff1891f","title":"Verpleegkundige cardiologie – 24-36 upw","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"7c707ab73c37","title":"Zorgassistent dialysecentrum","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"65c4bc79f7cb","title":"Dialyseverpleegkundige i.o.","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"f8ed695dc51a","title":"Internist-nefroloog","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"e5852b419944","title":"Vacature — Cardiodevice technicus in opleiding","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"41d9bd4e8ce2","title":"Vacature — Cardiodevice technicus","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"5cb076315d82","title":"Vacature — Leerling hartfunctielaborant","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"4ef55d9e6b5e","title":"Vacature — Promovendus vasculaire geneeskunde","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"96cebec5ba0c","title":"Doktersassistent polikliniek vaatchirurgie","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-10-05T03:34:19Z","type":"vacancy","id":"2b6ee91bc930","title":"Vacature — ANIOS Cardiologie","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"771f71832ab6","title":"CCU verpleegkundige in opleiding","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"bdc69f31b140","title":"CCU verpleegkundige","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"fca669e58eec","title":"Verpleegkundige Oncologie, Hematologie, Interne Geneeskunde en Nefrologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"b1afc36a1655","title":"Vacature — Promovendus 'TRAnslational Framework For Innovation in Cerebral amyloid angiopathy'","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"0ce89c0af2fa","title":"Fysiotherapeut Hart, Long & IC","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"5120d773b87a","title":"Echolaborant Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"7ca65778d026","title":"Dialyseverpleegkundige in opleiding","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"73e7d8d08721","title":"Radiologisch laborant all-round of met specialisatie MRI / echografie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"0b0d67e5add9","title":"(Medisch) Secretaresse Vakgroep Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"57cdf8b5cf85","title":"Vacature: Physician assistant afdeling Kort Verblijf Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"0fc80d82bcca","title":"Vacature: Praktijkbegeleider Nierziekten, Vaat- en Transplantatiechirurgie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"b1b109d4cc52","title":"Vacature — Promovendus Vasculaire Neurologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:18Z","type":"vacancy","id":"029b78f4496b","title":"Ikazia ziekenhuis | Vacature Vasculair Diagnostisch Laborant","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-10-05T03:34:17Z","type":"vacancy","id":"301d2b4d7811","title":"Verpleegkundige Cardiothoracale Chirurgie (CTC) - parttime of fulltime","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:17Z","type":"vacancy","id":"3d0e05ac9039","title":"Dialyse assistent in opleiding - parttime of fulltime","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:17Z","type":"vacancy","id":"640665765201","title":"Dialyseverpleegkundige in opleiding - parttime of fulltime","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:17Z","type":"vacancy","id":"f0d5d3ba63f8","title":"Capaciteitsplanner Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:17Z","type":"vacancy","id":"dcf846d5ce19","title":"Technisch Hartstimulatiespecialist","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:17Z","type":"vacancy","id":"0739e297b575","title":"Verpleegkundige Holding CardioVasculair interventiecentrum","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:17Z","type":"vacancy","id":"8731e82f1657","title":"Secretaresse /Planner Nefrologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-10-05T03:34:17Z","type":"vacancy","id":"94c67d87a298","title":"Cardiac Care (CCU) verpleegkundige in opleiding","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-10-05T03:34:17Z","type":"vacancy","id":"d6bd412f7d37","title":"Cardiac Care (CCU) verpleegkundige","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-10-02T12:54:57Z","type":"congress","id":"easd-2026","title":"EASD 2026 — Live vanuit Milaan","url":"https://hartvaat.nl/congres/easd-2026/","new":true},{"updated":"2026-10-02T12:44:29Z","type":"article","id":"easd26-live-slot-huisarts","title":"Slotbeschouwing EASD 2026: wat Milaan betekent voor de huisarts, internist en cardioloog, in vijf punten","url":"https://hartvaat.nl/2026/10/02/slotbeschouwing-easd-2026-wat-milaan-betekent-voor-de-huisarts-internist-en-card/","new":true},{"updated":"2026-10-02T12:43:14Z","type":"article","id":"easd26-live-ada-easd-consensus","title":"ADA/EASD-consensus 2026 over type 2-diabetes: SGLT2-remmer en/of GLP-1-middel mogelijk vanaf de diagnose, metformine niet langer de verplichte eerste stap, gewicht even belangrijk als glucose, finerenon als derde laag bij albuminurie","url":"https://hartvaat.nl/2026/10/02/ada-easd-consensus-2026-over-type-2-diabetes-sglt2-remmer-en-of-glp-1-middel-mog/","new":true},{"updated":"2026-10-02T09:15:34Z","type":"article","id":"easd26-live-finerenon-infinity","title":"Finerenon in Milaan: INFINITY-poolanalyse van 14.574 patiënten toont 24 procent minder nierfalen en 20 procent minder hartfalen of CV-sterfte, en volgens de EASD-subanalyses ongeacht HbA1c en BMI","url":"https://hartvaat.nl/2026/10/02/finerenon-in-milaan-infinity-poolanalyse-van-14-574-patienten-toont-24-procent-m/","new":true},{"updated":"2026-10-02T01:12:12Z","type":"article","id":"29a30ece354f","title":"Kanker en hypertensie: gedeelde mechanismen, medicatie-interacties en klinisch beheer","url":"https://hartvaat.nl/2026/10/01/kanker-en-hypertensie-gedeelde-mechanismen-medicatie-interacties-en-klinisch-beh/","new":true},{"updated":"2026-10-02T01:07:08Z","type":"article","id":"eb181754e559","title":"DASH-voedingsondersteuning door verpleegkundigen verlaagt bloeddruk bij ouderen met hypertensie","url":"https://hartvaat.nl/2026/10/01/dash-voedingsondersteuning-door-verpleegkundigen-verlaagt-bloeddruk-bij-ouderen-/","new":true},{"updated":"2026-10-02T00:56:54Z","type":"article","id":"84cbbe53feb2","title":"ART-gerelateerde gewichtstoename en viscerale adipositeit verhogen cardiometabool risico","url":"https://hartvaat.nl/2026/11/01/art-gerelateerde-gewichtstoename-en-viscerale-adipositeit-verhogen-cardiometaboo/","new":true},{"updated":"2026-10-02T00:53:03Z","type":"article","id":"55d5c6c81216","title":"Concomitante chirurgische AF-behandeling tijdens CABG verbetert langetermijnoverleving","url":"https://hartvaat.nl/2026/11/01/concomitante-chirurgische-af-behandeling-tijdens-cabg-verbetert-langetermijnover/","new":true},{"updated":"2026-10-02T00:47:26Z","type":"article","id":"583c8b545395","title":"Oxidatieve lipoproteïnen als onafhankelijke drijver van atherogenese — mechanismen en therapie","url":"https://hartvaat.nl/2027/01/01/oxidatieve-lipoproteinen-als-onafhankelijke-drijver-van-atherogenese-mechanismen/","new":true},{"updated":"2026-10-01T10:06:17Z","type":"article","id":"easd26-live-synchronize-2","title":"SYNCHRONIZE-2: de glucagon/GLP-1-agonist survodutide geeft bij obesitas met type 2-diabetes 13,1 procent gewichtsverlies en 1,2 procentpunt lager HbA1c, met 18 procent stakers door maag-darmklachten","url":"https://hartvaat.nl/2026/10/01/synchronize-2-de-glucagon-glp-1-agonist-survodutide-geeft-bij-obesitas-met-type-/","new":true},{"updated":"2026-10-01T03:59:07Z","type":"article","id":"easd26-live-eloratzp","title":"Lilly's amylinecombinatie: eloralintide plus tirzepatide geeft 23,3 procent gewichtsverlies bij obesitas met type 2-diabetes, tegen 14,8 procent met tirzepatide alleen, maar met tot 27 procent stakers","url":"https://hartvaat.nl/2026/10/01/lilly-s-amylinecombinatie-eloralintide-plus-tirzepatide-geeft-23-3-procent-gewic/","new":true},{"updated":"2026-10-01T03:59:00Z","type":"article","id":"easd26-live-achieve-4","title":"ACHIEVE-4: de GLP-1-pil orforglipron is cardiovasculair niet-inferieur aan insuline glargine bij type 2-diabetes met hoog risico, met een onbewezen sterftesignaal en drie keer minder hypoglykemie","url":"https://hartvaat.nl/2026/10/01/achieve-4-de-glp-1-pil-orforglipron-is-cardiovasculair-niet-inferieur-aan-insuli/","new":true},{"updated":"2026-09-30T14:54:12Z","type":"article","id":"easd26-live-cgm-richtlijn","title":"Eerste EASD-richtlijn over glucosesensoren bij type 2-diabetes: voorwaardelijk 'wij stellen voor' in alle groepen, HbA1c 0,32 procentpunt lager, bewijs van lage zekerheid","url":"https://hartvaat.nl/2026/09/30/eerste-easd-richtlijn-over-glucosesensoren-bij-type-2-diabetes-voorwaardelijk-wi/","new":true},{"updated":"2026-09-30T12:18:46Z","type":"article","id":"easd26-live-amyline","title":"Amyline in Milaan: CagriSema verlaagt HbA1c 0,16 procentpunt en gewicht 4 procentpunt meer dan semaglutide bij type 2-diabetes (REIMAGINE 2), zenagamtide volgt","url":"https://hartvaat.nl/2026/09/30/amyline-in-milaan-cagrisema-verlaagt-hba1c-0-16-procentpunt-en-gewicht-4-procent/","new":true},{"updated":"2026-09-30T08:36:18Z","type":"article","id":"easd26-live-triumph-2","title":"TRIUMPH-2: retatrutide geeft bij obesitas met type 2-diabetes tot 18,8 procent gewichtsverlies en 10,8 mmHg lagere bloeddruk, met hypotensie en dysesthesie als nieuwe signalen","url":"https://hartvaat.nl/2026/09/30/triumph-2-retatrutide-geeft-bij-obesitas-met-type-2-diabetes-tot-18-8-procent-ge/","new":true},{"updated":"2026-09-30T04:17:07Z","type":"podcastepisode","id":"78853","title":"#52: De prikkel van een pacemaker & de voordelen van vervelen","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-09-30T04:17:07Z","type":"podcastepisode","id":"78854","title":"Spreekuur Extra: wat doet roken met je ongeboren of pasgeboren kindje?","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-09-30T04:17:06Z","type":"podcastepisode","id":"78852","title":"Journal editorial: An optimally engineered pump, yet an incomplete therapy: biology, residual risk, and the future of LVAD care","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-09-30T04:06:20Z","type":"article","id":"easd26-live-glp1-bmi25","title":"Helft van de mensen met BMI 25 tot 27 heeft door remnant-cholesterol of ontsteking hetzelfde hartrisico als wie wél een GLP-1-agonist mag: Deense cohortanalyse","url":"https://hartvaat.nl/2026/09/30/helft-van-de-mensen-met-bmi-25-tot-27-heeft-door-remnant-cholesterol-of-ontsteki/","new":true},{"updated":"2026-09-30T01:32:25Z","type":"article","id":"71a6f879d198","title":"Diagnose van cardiale amyloïdose blijft vertraagd in Egypte — hoge sterfte bij presentatie","url":"https://hartvaat.nl/2026/09/29/diagnose-van-cardiale-amyloidose-blijft-vertraagd-in-egypte-hoge-sterfte-bij-pre/","new":true},{"updated":"2026-09-30T01:28:17Z","type":"article","id":"e634c4fff5e2","title":"CSC-status beïnvloedt slagofferregistratie na TAVR — TVTR-registry","url":"https://hartvaat.nl/2026/09/29/csc-status-beinvloedt-slagofferregistratie-na-tavr-tvtr-registry/","new":true},{"updated":"2026-09-30T01:23:01Z","type":"article","id":"b6f2d3c8a298","title":"Intra-annulaire Navitor-klep biedt veilige en effectieve valve-in-valve TAVR — NAViV-registry","url":"https://hartvaat.nl/2026/09/29/intra-annulaire-navitor-klep-biedt-veilige-en-effectieve-valve-in-valve-tavr-nav/","new":true},{"updated":"2026-09-30T01:18:07Z","type":"article","id":"ba6f18eb3e69","title":"Complicaties na TAVI volgens VARC-3: incidentie, voorspellers en mortaliteit","url":"https://hartvaat.nl/2026/09/29/complicaties-na-tavi-volgens-varc-3-incidentie-voorspellers-en-mortaliteit/","new":true},{"updated":"2026-09-30T01:12:44Z","type":"article","id":"6f708affc6ac","title":"Semaglutide verlaagt inflammatoire monocyten en beenmergactiviteit bij diabetes type 2","url":"https://hartvaat.nl/2026/09/29/semaglutide-verlaagt-inflammatoire-monocyten-en-beenmergactiviteit-bij-diabetes-/","new":true},{"updated":"2026-09-30T01:06:58Z","type":"article","id":"2b3a191ee8aa","title":"LOX-1-NLRP3-as verklaart residuair inflammatoir risico bij atherosclerose","url":"https://hartvaat.nl/2026/09/29/lox-1-nlrp3-as-verklaart-residuair-inflammatoir-risico-bij-atherosclerose/","new":true},{"updated":"2026-09-30T01:01:30Z","type":"article","id":"878adc86e7d0","title":"Niet-dippen bij chronische nierziekte gekoppeld aan hoger sterfterisico en CV-events — meta-analyse","url":"https://hartvaat.nl/2026/09/29/niet-dippen-bij-chronische-nierziekte-gekoppeld-aan-hoger-sterfterisico-en-cv-ev/","new":true},{"updated":"2026-09-30T00:58:06Z","type":"article","id":"9ceea6fa9811","title":"hs-cTnT-niveaus wijzen op risico acute nierinsufficiëntie in de spoedeisende hulp","url":"https://hartvaat.nl/2026/09/29/hs-ctnt-niveaus-wijzen-op-risico-acute-nierinsufficientie-in-de-spoedeisende-hul/","new":true},{"updated":"2026-09-30T00:52:32Z","type":"article","id":"60deb7eda928","title":"Lage fysieke fitheid verhoogt hartfalen- en sterfterisico bij CKD — CRIC","url":"https://hartvaat.nl/2026/09/29/lage-fysieke-fitheid-verhoogt-hartfalen-en-sterfterisico-bij-ckd-cric/","new":true},{"updated":"2026-09-30T00:48:56Z","type":"article","id":"b7f9c285710e","title":"Ancestryverschillen in hartfalen en MACE bij volwassenen met aangeboren hartafwijkingen — All of Us","url":"https://hartvaat.nl/2026/09/29/ancestryverschillen-in-hartfalen-en-mace-bij-volwassenen-met-aangeboren-hartafwi/","new":true},{"updated":"2026-09-29T13:44:25Z","type":"article","id":"easd26-live-fabrikantenduel","title":"Novo tegen Lilly in Milaan: semaglutide ophogen of overstappen op tirzepatide, en orforglipron tegen orale semaglutide, in niet-gerandomiseerde vergelijkingen","url":"https://hartvaat.nl/2026/09/29/novo-tegen-lilly-in-milaan-semaglutide-ophogen-of-overstappen-op-tirzepatide-en-/","new":true},{"updated":"2026-09-29T09:17:42Z","type":"article","id":"easd26-dossier-pijplijn","title":"Na semaglutide: de nieuwe generatie cardiometabole middelen in vier routes, van pil tot drievoudige agonist","url":"https://hartvaat.nl/2026/09/29/na-semaglutide-de-nieuwe-generatie-cardiometabole-middelen-in-vier-routes-van-pi/","new":true},{"updated":"2026-09-29T09:11:09Z","type":"article","id":"easd26-live-semaglutide-pancreas","title":"Semaglutide geeft geen verhoogd risico op pancreaskanker: Scandinavische registerstudie met bijna 100.000 gebruikers","url":"https://hartvaat.nl/2026/09/29/semaglutide-geeft-geen-verhoogd-risico-op-pancreaskanker-scandinavische-register/","new":true},{"updated":"2026-09-29T09:11:09Z","type":"article","id":"easd26-live-transcend-t2d-1","title":"TRANSCEND-T2D-1: retatrutide als monotherapie verlaagt HbA1c met tot 1,1 procentpunt meer dan placebo en gewicht met tot 15 procent","url":"https://hartvaat.nl/2026/09/29/transcend-t2d-1-retatrutide-als-monotherapie-verlaagt-hba1c-met-tot-1-1-procentp/","new":true},{"updated":"2026-09-29T09:11:08Z","type":"article","id":"easd26-live-calor-trajecten","title":"Binnen tien jaar na de diagnose type 2-diabetes krijgt 55 procent chronische nierschade of hartfalen, of overlijdt: data van 1,6 miljoen patiënten","url":"https://hartvaat.nl/2026/09/29/binnen-tien-jaar-na-de-diagnose-type-2-diabetes-krijgt-55-procent-chronische-nie/","new":true},{"updated":"2026-09-29T09:11:08Z","type":"article","id":"easd26-live-bp-variabiliteit","title":"Bloeddrukvariabiliteit tussen bezoeken voorspelt sterfte en beroerte, ook bij gelijke gemiddelde bloeddruk: Amsterdam UMC-analyse in de UK Biobank","url":"https://hartvaat.nl/2026/09/29/bloeddrukvariabiliteit-tussen-bezoeken-voorspelt-sterfte-en-beroerte-ook-bij-gel/","new":true},{"updated":"2026-09-29T09:05:49Z","type":"article","id":"4b3b7465d8a0","title":"FLOW: semaglutide beschermt nieren bij type 2 diabetes en CKD — NEJM-gerelateerd","url":"https://hartvaat.nl/2024/07/11/flow-semaglutide-beschermt-nieren-bij-type-2-diabetes-en-ckd-nejm-gerelateerd/","new":false},{"updated":"2026-09-29T09:05:49Z","type":"article","id":"b7cc7318df53","title":"Retatrutide: triple GIP/GLP-1/glucagonagonist bij type 2 diabetes — Lancet fase 2","url":"https://hartvaat.nl/2023/08/12/retatrutide-triple-gip-glp-1-glucagonagonist-bij-type-2-diabetes-lancet-fase-2/","new":false},{"updated":"2026-09-29T09:05:49Z","type":"article","id":"105ff3260dd0","title":"Langetermijneffect van metformine en leefstijlinterventie op cardiovasculaire events","url":"https://hartvaat.nl/2022/05/31/langetermijneffect-van-metformine-en-leefstijlinterventie-op-cardiovasculaire-ev/","new":false},{"updated":"2026-09-29T09:05:49Z","type":"article","id":"175deea1f4be","title":"Finerenon CV en renale uitkomsten bij diabetes met CKD: FIDELITY gepoolde analyse","url":"https://hartvaat.nl/2022/02/10/finerenon-cv-en-renale-uitkomsten-bij-diabetes-met-ckd-fidelity-gepoolde-analyse/","new":false},{"updated":"2026-09-29T09:05:49Z","type":"article","id":"84839401e677","title":"Tirzepatide versus insuline glargine bij diabetes type 2 met hoog CV-risico: Lancet SURPASS-4","url":"https://hartvaat.nl/2021/11/13/tirzepatide-versus-insuline-glargine-bij-diabetes-type-2-met-hoog-cv-risico-lanc/","new":false},{"updated":"2026-09-29T09:05:49Z","type":"article","id":"e1c52754d5a0","title":"SGLT2-remmers en lager risico op hartfalen en sterfte versus andere glucoseverlagers: real-world","url":"https://hartvaat.nl/2017/07/18/sglt2-remmers-en-lager-risico-op-hartfalen-en-sterfte-versus-andere-glucoseverla/","new":false},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"e1adbe29eabb","title":"Orforglipron: stabiele nierfunctie in fase-3-trials, maar nier-specifieke uitkomsten blijven onduidelijk","url":"https://hartvaat.nl/2026/09/09/orforglipron-stabiele-nierfunctie-in-fase-3-trials-maar-nier-specifieke-uitkomst/","new":true},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"c4d53c72493d","title":"GLP-1-agonisten en SGLT2-remmers voor preventie van type 2-diabetes bij obesitas","url":"https://hartvaat.nl/2026/09/03/glp-1-agonisten-en-sglt2-remmers-voor-preventie-van-type-2-diabetes-bij-obesitas/","new":false},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"924c96dc3ecd","title":"GLP-1- en dual-receptoragonisten: nieuwe consensus over toepassing bij type 2-diabetes","url":"https://hartvaat.nl/2026/08/25/glp-1-en-dual-receptoragonisten-nieuwe-consensus-over-toepassing-bij-type-2-diab/","new":false},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"3ba9fe90441b","title":"Finerenon effectief bij type 1 diabetes met chronische nierziekte","url":"https://hartvaat.nl/2026/03/05/finerenon-effectief-bij-type-1-diabetes-met-chronische-nierziekte/","new":false},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"fb10fc259655","title":"GLP-1-agonisten versus DPP-4-remmers en SGLT2-remmers bij hartfalenrisico","url":"https://hartvaat.nl/2026/02/24/glp-1-agonisten-versus-dpp-4-remmers-en-sglt2-remmers-bij-hartfalenrisico/","new":false},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"de3884c92492","title":"CagriSema verlaagt bloeddruk bij overgewicht/obesitas: REDEFINE 1","url":"https://hartvaat.nl/2026/02/01/cagrisema-verlaagt-bloeddruk-bij-overgewicht-obesitas-redefine-1/","new":false},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"51d855798fd2","title":"Tirzepatide versus dulaglutide en CV-uitkomsten bij type 2 diabetes","url":"https://hartvaat.nl/2025/12/18/tirzepatide-versus-dulaglutide-en-cv-uitkomsten-bij-type-2-diabetes/","new":false},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"11009b1a646d","title":"Orforglipron bij vroeg type 2 diabetes: NEJM fase 3","url":"https://hartvaat.nl/2025/09/18/orforglipron-bij-vroeg-type-2-diabetes-nejm-fase-3/","new":false},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"262f725f1d71","title":"CagriSema: gecombineerd cagrilintide en semaglutide bij overgewicht — NEJM","url":"https://hartvaat.nl/2025/08/14/cagrisema-gecombineerd-cagrilintide-en-semaglutide-bij-overgewicht-nejm/","new":false},{"updated":"2026-09-29T09:05:48Z","type":"article","id":"5a99a79159a6","title":"Amycretine: eerste GLP-1/amyline-agonist — fase 1 veiligheid en farmacologie","url":"https://hartvaat.nl/2025/07/12/amycretine-eerste-glp-1-amyline-agonist-fase-1-veiligheid-en-farmacologie/","new":false},{"updated":"2026-09-29T05:34:17Z","type":"article","id":"healthtech-nexus-micro-athlete-2026","title":"Wanneer is bewegen schadelijk? Onderzoek op minihart geeft antwoorden","url":"https://hartvaat.nl/2026/09/29/wanneer-is-bewegen-schadelijk-onderzoek-op-minihart-geeft-antwoorden/","new":true},{"updated":"2026-09-29T05:34:17Z","type":"event","id":"78811","title":"TechMed Event 2026: Het Ziekenhuis van de Toekomst","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-09-29T05:34:17Z","type":"organiser","id":"78810","title":"Universiteit Twente","url":"https://hartvaat.nl/agenda/","new":true},{"updated":"2026-09-28T03:37:54Z","type":"vacancy","id":"0c8dff0990ca","title":"Opleidingsplek Verpleegkundige Interventie Cardiologie","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-09-28T03:37:54Z","type":"vacancy","id":"3f7835e30d45","title":"MHV Traineeship Interventie Cardiologie","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-09-28T03:37:53Z","type":"vacancy","id":"1df0f240939b","title":"Vacature — CCU verpleegkundige in opleiding","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:52Z","type":"vacancy","id":"de1652886106","title":"Kom werken als hartfunctie-laborant, specialisatie echocardiografie bij Noordwest","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:52Z","type":"vacancy","id":"65079dee7b28","title":"Kom werken als Verpleegkundige vaat- en traumachirurgie (snijdend) bij Noordwest","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:52Z","type":"vacancy","id":"7ca61a98c04f","title":"ANIOS Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:52Z","type":"vacancy","id":"cccd6cc9b5b2","title":"Radiologisch laborant met specialisatie echografie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:52Z","type":"vacancy","id":"55388c29a406","title":"Medisch assistent Echografie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:52Z","type":"vacancy","id":"3d275142478b","title":"Vacature: Teammanager verpleegkundig team poliklinieken Longgeneeskunde en Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:52Z","type":"vacancy","id":"37a9f75befc0","title":"Vacature: Verpleegkundige Interventiecardiologie in opleiding","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:52Z","type":"vacancy","id":"ab579d14b9c0","title":"Ikazia ziekenhuis | Vacature Doktersassistent Cardiologie","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-09-28T03:37:51Z","type":"vacancy","id":"f2cf8c61b47c","title":"Vacature: Arts promovendus Structurele Hartziekten","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:51Z","type":"vacancy","id":"ac106c169748","title":"Vacature: Kindercardioloog en/of fellow kindercardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:51Z","type":"vacancy","id":"ef0843a2e86a","title":"Traineeship Hartcentrum","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:51Z","type":"vacancy","id":"c78bf3c53152","title":"Chef de Clinique interventiecardioloog - parttime/fulltime","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:51Z","type":"vacancy","id":"3c1ed99f09fe","title":"Doktersassistent Polikliniek Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:51Z","type":"vacancy","id":"8d192c174933","title":"Medisch Hulpverlener CCU, opleidingsplaats","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T03:37:51Z","type":"vacancy","id":"c58c6e028e15","title":"Interventiemedewerker cardiologie in opleiding - Amphia","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-28T01:29:37Z","type":"article","id":"3004c76fb39d","title":"AI-gestuurde fenotypisering van HFpEF onthult vroege en late ziektestadia — EHR-cohortstudie","url":"https://hartvaat.nl/2026/09/25/ai-gestuurde-fenotypisering-van-hfpef-onthult-vroege-en-late-ziektestadia-ehr-co/","new":true},{"updated":"2026-09-28T01:25:52Z","type":"article","id":"b42870b840c0","title":"Ernstige mitralisklepringscalcificatie correleert met invasief bewijs van HFpEF","url":"https://hartvaat.nl/2026/09/25/ernstige-mitralisklepringscalcificatie-correleert-met-invasief-bewijs-van-hfpef/","new":true},{"updated":"2026-09-28T01:21:55Z","type":"article","id":"f4f792f6ed60","title":"TyG-BMI correleert met versnelde vaatveroudering bij jongere volwassenen","url":"https://hartvaat.nl/2026/09/25/tyg-bmi-correleert-met-versnelde-vaatveroudering-bij-jongere-volwassenen/","new":true},{"updated":"2026-09-28T01:17:28Z","type":"article","id":"a8779844de09","title":"ACEi/ARB/ARNi verlagen mortaliteit bij AL-cardiale amyloïdose","url":"https://hartvaat.nl/2026/09/26/acei-arb-arni-verlagen-mortaliteit-bij-al-cardiale-amyloidose/","new":true},{"updated":"2026-09-28T01:11:24Z","type":"article","id":"e7f7273bf957","title":"GLP-1-remmers verlagen MACE en heropnames bij HFpEF — meta-analyse","url":"https://hartvaat.nl/2026/09/26/glp-1-remmers-verlagen-mace-en-heropnames-bij-hfpef-meta-analyse/","new":true},{"updated":"2026-09-28T01:07:39Z","type":"article","id":"6ec6f1419a48","title":"Lagere non-Lp(a) apoB/Lp(a)-verhouding correleert met kwetsbaarder plaques — PROSPECT II","url":"https://hartvaat.nl/2026/09/26/lagere-non-lp-a-apob-lp-a-verhouding-correleert-met-kwetsbaarder-plaques-prospec/","new":true},{"updated":"2026-09-28T01:03:55Z","type":"article","id":"34025501b8ab","title":"Langdurig beloop jeugdige nefrotisch syndroom: recidieven en cardiovasculair risico in volwassenheid","url":"https://hartvaat.nl/2026/09/26/langdurig-beloop-jeugdige-nefrotisch-syndroom-recidieven-en-cardiovasculair-risi/","new":true},{"updated":"2026-09-28T00:58:54Z","type":"article","id":"9e0598b3bd29","title":"PFA toont superieure veiligheid en betere uitkomsten na AF-ablatie — POL-AR","url":"https://hartvaat.nl/2026/09/27/pfa-toont-superieure-veiligheid-en-betere-uitkomsten-na-af-ablatie-pol-ar/","new":true},{"updated":"2026-09-28T00:51:16Z","type":"article","id":"8ab361d089db","title":"Klinische kwetsbaarheid beter dan leeftijd alleen voor voorspellen recidief na AF-ablatie","url":"https://hartvaat.nl/2026/10/01/klinische-kwetsbaarheid-beter-dan-leeftijd-alleen-voor-voorspellen-recidief-na-a/","new":true},{"updated":"2026-09-28T00:47:25Z","type":"article","id":"575e66a9da31","title":"Darmmicrobioot-afgeleid IPA is lager bij T2D en gekoppeld aan glycemische variabiliteit","url":"https://hartvaat.nl/2026/12/31/darmmicrobioot-afgeleid-ipa-is-lager-bij-t2d-en-gekoppeld-aan-glycemische-variab/","new":true},{"updated":"2026-09-26T01:28:03Z","type":"article","id":"430062927aa8","title":"AF-ablatie na LAAO-implantatie is veilig; korte OAC-fase volstaat bij hoogbloedingsrisico","url":"https://hartvaat.nl/2026/09/25/af-ablatie-na-laao-implantatie-is-veilig-korte-oac-fase-volstaat-bij-hoogbloedin/","new":true},{"updated":"2026-09-26T01:23:16Z","type":"article","id":"7d06d3f6dbd6","title":"Lead V8 op het ECG evalueert linkervoorhartactivering tijdens Bachmann-bundelpacemaking","url":"https://hartvaat.nl/2026/09/25/lead-v8-op-het-ecg-evalueert-linkervoorhartactivering-tijdens-bachmann-bundelpac/","new":true},{"updated":"2026-09-26T01:18:10Z","type":"article","id":"d96aa598e27b","title":"Lerodalcibep-ligand biedt eenmaal maandelijks PCSK9-remming met 50 tot 65% LDL-C-verlaging","url":"https://hartvaat.nl/2026/09/25/lerodalcibep-ligand-biedt-eenmaal-maandelijks-pcsk9-remming-met-50-tot-65-ldl-c-/","new":true},{"updated":"2026-09-26T01:13:54Z","type":"article","id":"b43383e82185","title":"Denosumab beïnvloedt vaatcalcificatie niet bij dialysepatiënten — meta-analyse","url":"https://hartvaat.nl/2026/09/25/denosumab-beinvloedt-vaatcalcificatie-niet-bij-dialysepatienten-meta-analyse/","new":true},{"updated":"2026-09-26T01:10:03Z","type":"article","id":"710ca3fb48be","title":"Hoge RAR-waarde geassocieerd met sterfte bij chronische nierziekte — NHANES","url":"https://hartvaat.nl/2026/09/25/hoge-rar-waarde-geassocieerd-met-sterfte-bij-chronische-nierziekte-nhanes/","new":true},{"updated":"2026-09-26T01:02:57Z","type":"article","id":"4f5d3ca88325","title":"Cardiovasculaire uitkomsten bij coronaire microvasculaire dysfunctie — FLOW-CMD Registry","url":"https://hartvaat.nl/2026/09/26/cardiovasculaire-uitkomsten-bij-coronaire-microvasculaire-dysfunctie-flow-cmd-re/","new":true},{"updated":"2026-09-26T00:59:49Z","type":"article","id":"9d2e9b1bafc0","title":"Metoprolol verbetert uitkomsten niet bij COPD zonder hart- en vaatziekten","url":"https://hartvaat.nl/2026/10/01/metoprolol-verbetert-uitkomsten-niet-bij-copd-zonder-hart-en-vaatziekten/","new":true},{"updated":"2026-09-26T00:56:11Z","type":"article","id":"d289606f32c6","title":"CKM-multimorbiditeit verhoogt sterfterisico bij hartfalen — Chinese registry","url":"https://hartvaat.nl/2026/10/01/ckm-multimorbiditeit-verhoogt-sterfterisico-bij-hartfalen-chinese-registry/","new":true},{"updated":"2026-09-26T00:51:31Z","type":"article","id":"426f7c29d77e","title":"Incidentie beroerte bij jongvolwassenen stijgt — geassocieerd met hypertensie, diabetes en middelengebruik","url":"https://hartvaat.nl/2026/10/27/incidentie-beroerte-bij-jongvolwassenen-stijgt-geassocieerd-met-hypertensie-diab/","new":true},{"updated":"2026-09-26T00:47:52Z","type":"article","id":"75ae66150b87","title":"Cuffless draagbaar meetapparaat volgt bloeddrukveranderingen stabiel bij hypertensiepatiënten","url":"https://hartvaat.nl/2026/12/01/cuffless-draagbaar-meetapparaat-volgt-bloeddrukveranderingen-stabiel-bij-hyperte/","new":true},{"updated":"2026-09-24T01:22:24Z","type":"article","id":"2bd862c149e6","title":"Ondiagnostische chronische nierziekte bij hartfalen en cardiovasculaire uitkomsten — FINEARTS-HF","url":"https://hartvaat.nl/2026/09/23/ondiagnostische-chronische-nierziekte-bij-hartfalen-en-cardiovasculaire-uitkomst/","new":true},{"updated":"2026-09-24T01:19:41Z","type":"article","id":"d796174382d2","title":"Bioimpedancemeting als hulpmiddel bij congestie bij hartfalen","url":"https://hartvaat.nl/2026/09/23/bioimpedancemeting-als-hulpmiddel-bij-congestie-bij-hartfalen/","new":true},{"updated":"2026-09-24T01:14:55Z","type":"article","id":"95ce09188c9c","title":"Cardiale revalidatie verbetert belastbaarheid bij hartfalenexacerbatie","url":"https://hartvaat.nl/2026/09/24/cardiale-revalidatie-verbetert-belastbaarheid-bij-hartfalenexacerbatie/","new":true},{"updated":"2026-09-24T01:10:09Z","type":"article","id":"3cc2c0cdd2d4","title":"Nomogram voorspelt risico op primair aldosteronisme bij hypertensiepatiënten","url":"https://hartvaat.nl/2026/09/24/nomogram-voorspelt-risico-op-primair-aldosteronisme-bij-hypertensiepatienten/","new":true},{"updated":"2026-09-24T01:06:14Z","type":"article","id":"fb3bcd7ff319","title":"GLP-1-agonisten verlagen sterfte bij HFpEF met obesitas, maar niet bij atriumfibrilleren","url":"https://hartvaat.nl/2026/10/01/glp-1-agonisten-verlagen-sterfte-bij-hfpef-met-obesitas-maar-niet-bij-atriumfibr/","new":true},{"updated":"2026-09-24T01:03:10Z","type":"article","id":"91c2a842dd31","title":"Verhoogd lipoproteïne(a) geassocieerd met kwetsbare coronaire plaques — meta-analyse","url":"https://hartvaat.nl/2026/10/01/verhoogd-lipoproteine-a-geassocieerd-met-kwetsbare-coronaire-plaques-meta-analys/","new":true},{"updated":"2026-09-24T00:59:59Z","type":"article","id":"655c598f58b0","title":"Plantaardig nitraat en nitriet verlagen hypertensierisico — Tehran Lipid and Glucose Study","url":"https://hartvaat.nl/2026/10/01/plantaardig-nitraat-en-nitriet-verlagen-hypertensierisico-tehran-lipid-and-gluco/","new":true},{"updated":"2026-09-24T00:55:13Z","type":"article","id":"88e69bc1d8b8","title":"Atenolol verlaagt MACE na myocardinfarct — vergelijk met bisoprolol","url":"https://hartvaat.nl/2026/10/01/atenolol-verlaagt-mace-na-myocardinfarct-vergelijk-met-bisoprolol/","new":true},{"updated":"2026-09-24T00:51:36Z","type":"article","id":"82626d9c2f39","title":"Verhoogd lipoproteïne(a) hangt samen met aortaplakruptuur — NOGA-studie","url":"https://hartvaat.nl/2026/12/01/verhoogd-lipoproteine-a-hangt-samen-met-aortaplakruptuur-noga-studie/","new":true},{"updated":"2026-09-24T00:46:34Z","type":"article","id":"6e6021542628","title":"Obesitas in Spanje: hoge prevalentie, veel cardiorenale complicaties en zorgkloof — systematisch overzicht","url":"https://hartvaat.nl/2026/12/01/obesitas-in-spanje-hoge-prevalentie-veel-cardiorenale-complicaties-en-zorgkloof-/","new":true},{"updated":"2026-09-23T04:17:07Z","type":"podcastepisode","id":"78093","title":"#51: De vape-epidemie: een levensgevaarlijk massa-experiment","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-09-23T04:17:06Z","type":"podcastepisode","id":"78092","title":"Journal editorial: Seeing is not knowing: risk, regulation, and the modern donor heart","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-09-22T01:20:14Z","type":"article","id":"8102eab6fc1d","title":"Abnormale myocardiale strain op CMR bij kinderen met gevorderde chronische nierziekte — CKiD","url":"https://hartvaat.nl/2026/09/21/abnormale-myocardiale-strain-op-cmr-bij-kinderen-met-gevorderde-chronische-nierz/","new":true},{"updated":"2026-09-22T01:17:30Z","type":"article","id":"e28c4ab8a4a5","title":"Hogere bloed-seleniumspiegels gekoppeld aan lagere sterfte bij CKM-syndroom — NHANES-cohort","url":"https://hartvaat.nl/2026/09/21/hogere-bloed-seleniumspiegels-gekoppeld-aan-lagere-sterfte-bij-ckm-syndroom-nhan/","new":true},{"updated":"2026-09-22T01:13:56Z","type":"article","id":"1eceaa6de3fa","title":"Macroalbuminurie wijst op hartstructurele schade bij diabetes en nierinsufficiëntie","url":"https://hartvaat.nl/2026/09/21/macroalbuminurie-wijst-op-hartstructurele-schade-bij-diabetes-en-nierinsufficien/","new":true},{"updated":"2026-09-22T01:11:15Z","type":"article","id":"03724c5300ce","title":"SGLT2-remmers, GLP-1-agonisten en MRAs herschrijven de HFpEF-behandeling — pathofysiologische synthese","url":"https://hartvaat.nl/2026/09/21/sglt2-remmers-glp-1-agonisten-en-mras-herschrijven-de-hfpef-behandeling-pathofys/","new":true},{"updated":"2026-09-22T01:06:22Z","type":"article","id":"071f4d34016d","title":"ACS bij Kawasaki-ziekte: gespecialiseerde beeldvorming en aangepaste antithrombotische therapie","url":"https://hartvaat.nl/2026/09/22/acs-bij-kawasaki-ziekte-gespecialiseerde-beeldvorming-en-aangepaste-antithrombot/","new":true},{"updated":"2026-09-22T01:01:50Z","type":"article","id":"4eb483117c68","title":"Post-captopril-aldosteron voorspelt progressie naar CKM-stadium 4 bij primair aldosteronisme","url":"https://hartvaat.nl/2026/09/22/post-captopril-aldosteron-voorspelt-progressie-naar-ckm-stadium-4-bij-primair-al/","new":true},{"updated":"2026-09-22T00:59:03Z","type":"article","id":"abd1608e4c39","title":"Precision genome editing als potentieel eenmalige therapie voor hyperlipidemie","url":"https://hartvaat.nl/2026/10/28/precision-genome-editing-als-potentieel-eenmalige-therapie-voor-hyperlipidemie/","new":true},{"updated":"2026-09-22T00:54:37Z","type":"article","id":"6da252f28a31","title":"Dapagliflozin geassocieerd met minder urineweginfecties dan empagliflozin bij diabetische vrouwen","url":"https://hartvaat.nl/2026/10/31/dapagliflozin-geassocieerd-met-minder-urineweginfecties-dan-empagliflozin-bij-di/","new":true},{"updated":"2026-09-22T00:51:14Z","type":"article","id":"77029ad3c6fc","title":"TAVI-leveringen vergelijkbaar bij tricuspidale, bicuspidale en bioprosthetische kleppen — COMPARE-TAVI 1","url":"https://hartvaat.nl/2026/12/01/tavi-leveringen-vergelijkbaar-bij-tricuspidale-bicuspidale-en-bioprosthetische-k/","new":true},{"updated":"2026-09-22T00:46:06Z","type":"article","id":"b8086dfdae02","title":"Discrepantie in richtlijnen over laagwaardige zorg bij hart- en vaatziekten — narratieve review","url":"https://hartvaat.nl/2026/12/01/discrepantie-in-richtlijnen-over-laagwaardige-zorg-bij-hart-en-vaatziekten-narra/","new":true},{"updated":"2026-09-21T03:37:54Z","type":"vacancy","id":"ddd2f01657bc","title":"Vacature — Doktersassistent endocrinologie, vasculaire geneeskunde, infectieziekten (EVI) en nefrologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-21T03:37:54Z","type":"vacancy","id":"05d1e1b529c6","title":"Echografist","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-21T03:37:54Z","type":"vacancy","id":"226b6f07965e","title":"CCU Verpleegkundige","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-09-21T03:37:53Z","type":"vacancy","id":"e88d81e6b8a2","title":"Afdelingshoofd Hartinterventiecentrum","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-21T03:37:53Z","type":"vacancy","id":"dfbeb209fb98","title":"Promovendus Thuismonitoring bij hartfalen (PhD)","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-21T03:37:53Z","type":"vacancy","id":"2822fe0f23ac","title":"Algemeen Cardioloog, chef de clinique","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-21T03:37:53Z","type":"vacancy","id":"7f8d83e113fc","title":"Physician Assistant Hartcentrum - parttime","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-09-20T01:41:29Z","type":"article","id":"99ba4f5db50c","title":"SGLT2-remmers perioperatief: afweging tussen euDKA-risico en cardiorenale bescherming","url":"https://hartvaat.nl/2026/09/18/sglt2-remmers-perioperatief-afweging-tussen-eudka-risico-en-cardiorenale-bescher/","new":true},{"updated":"2026-09-20T01:38:24Z","type":"article","id":"b254d3440bd9","title":"Niertransplantatie met standaardcriteria-donor verhoogt overleving ten opzichte van dialyse","url":"https://hartvaat.nl/2026/09/18/niertransplantatie-met-standaardcriteria-donor-verhoogt-overleving-ten-opzichte-/","new":true},{"updated":"2026-09-20T01:34:47Z","type":"article","id":"c11fd82c4688","title":"CKM-syndroom: epidemiologie, prognose en de nieuwe 2026-richtlijn","url":"https://hartvaat.nl/2026/09/18/ckm-syndroom-epidemiologie-prognose-en-de-nieuwe-2026-richtlijn/","new":true},{"updated":"2026-09-20T01:28:22Z","type":"article","id":"2e9400edc3f3","title":"SAVR, Ozaki en TAVI bij aortastenose: vergelijkbare vroege uitkomsten, Ozaki toont gunstigere hemodynamiek op 6 maanden","url":"https://hartvaat.nl/2026/09/18/savr-ozaki-en-tavi-bij-aortastenose-vergelijkbare-vroege-uitkomsten-ozaki-toont-/","new":true},{"updated":"2026-09-20T01:17:43Z","type":"article","id":"aaa22cb23653","title":"Hoge neutrofiel-HDL-ratio correleert met meer hart- en vaatziekten bij COPD — NHANES","url":"https://hartvaat.nl/2026/09/18/hoge-neutrofiel-hdl-ratio-correleert-met-meer-hart-en-vaatziekten-bij-copd-nhane/","new":true},{"updated":"2026-09-20T01:12:56Z","type":"article","id":"5cc944104ed3","title":"Hogere MHR-waarde correleert met hart- en vaatziekten bij COPD-patiënten","url":"https://hartvaat.nl/2026/09/18/hogere-mhr-waarde-correleert-met-hart-en-vaatziekten-bij-copd-patienten/","new":true},{"updated":"2026-09-20T01:08:49Z","type":"article","id":"9432b7888210","title":"Cardiale afwijkingen komen vaak voor bij NF1 — geadviseerd wordt regelmatige screening","url":"https://hartvaat.nl/2026/09/19/cardiale-afwijkingen-komen-vaak-voor-bij-nf1-geadviseerd-wordt-regelmatige-scree/","new":true},{"updated":"2026-09-20T01:05:51Z","type":"article","id":"19d0baa6873c","title":"Nieuwe lipidendalers bieden meer opties voor kinderen met familiaire hypercholesterolemie","url":"https://hartvaat.nl/2026/09/19/nieuwe-lipidendalers-bieden-meer-opties-voor-kinderen-met-familiaire-hypercholes/","new":true},{"updated":"2026-09-20T00:51:02Z","type":"article","id":"944aae535a75","title":"Genetische variant verklaart bias in creatinine-eGFR bij patiënten van Afrikaanse afkomst","url":"https://hartvaat.nl/2026/09/26/genetische-variant-verklaart-bias-in-creatinine-egfr-bij-patienten-van-afrikaans/","new":true},{"updated":"2026-09-20T00:46:10Z","type":"article","id":"5782603a2a90","title":"SGLT2-remmers verbeteren ventriculaire elektrische stabiliteit op ECG — meta-analyse","url":"https://hartvaat.nl/2026/10/01/sglt2-remmers-verbeteren-ventriculaire-elektrische-stabiliteit-op-ecg-meta-analy/","new":true},{"updated":"2026-09-18T01:27:11Z","type":"article","id":"d7b44cd47df4","title":"Glucosurie duidt op adherence aan SGLT2-remmers en correleert met minder sterfte en hartfalen","url":"https://hartvaat.nl/2026/09/17/glucosurie-duidt-op-adherence-aan-sglt2-remmers-en-correleert-met-minder-sterfte/","new":true},{"updated":"2026-09-18T01:23:34Z","type":"article","id":"ea2ada7ee725","title":"Orale semaglutide verlaagt cardiovasculaire uitkomsten bij diabetes en ASCVD — real-world studie","url":"https://hartvaat.nl/2026/09/17/orale-semaglutide-verlaagt-cardiovasculaire-uitkomsten-bij-diabetes-en-ascvd-rea/","new":true},{"updated":"2026-09-18T01:19:21Z","type":"article","id":"c875d050d663","title":"Lp(a)-spiegels stijgen tijdens menopauze — herhaalde bepaling nodig bij vrouwen met tussenliggende baseline","url":"https://hartvaat.nl/2026/09/17/lp-a-spiegels-stijgen-tijdens-menopauze-herhaalde-bepaling-nodig-bij-vrouwen-met/","new":true},{"updated":"2026-09-18T01:14:50Z","type":"article","id":"dd001e93361d","title":"Paclitaxel-behandelde ballonnen behouden effectiviteit bij in-stentrestenose, ongeacht nierfunctie","url":"https://hartvaat.nl/2026/09/17/paclitaxel-behandelde-ballonnen-behouden-effectiviteit-bij-in-stentrestenose-ong/","new":true},{"updated":"2026-09-18T01:11:07Z","type":"article","id":"6d2d69ada8f0","title":"Sex-specifieke zorg en cardiorenale monitoring bij vrouwen met chronische nierziekte — AHA-statement","url":"https://hartvaat.nl/2026/09/17/sex-specifieke-zorg-en-cardiorenale-monitoring-bij-vrouwen-met-chronische-nierzi/","new":true},{"updated":"2026-09-18T01:08:03Z","type":"article","id":"089e4e107bef","title":"Combinatie balcanrenone en dapagliflozin veroorzaakt reversibele eGFR-daling bij CKD — MIRO-CKD","url":"https://hartvaat.nl/2026/09/17/combinatie-balcanrenone-en-dapagliflozin-veroorzaakt-reversibele-egfr-daling-bij/","new":true},{"updated":"2026-09-18T01:02:11Z","type":"article","id":"1549dffe0e13","title":"Hoge arsenicum- en nikkelexpositie gekoppeld aan hart- en vaatziekten bij dyslipidemie","url":"https://hartvaat.nl/2026/09/17/hoge-arsenicum-en-nikkelexpositie-gekoppeld-aan-hart-en-vaatziekten-bij-dyslipid/","new":true},{"updated":"2026-09-18T00:54:26Z","type":"article","id":"cfeddff20224","title":"Multimodale rechterhartmonitoring biedt kader voor hartfalenverloop — conceptueel overzicht","url":"https://hartvaat.nl/2026/10/01/multimodale-rechterhartmonitoring-biedt-kader-voor-hartfalenverloop-conceptueel-/","new":true},{"updated":"2026-09-18T00:51:31Z","type":"article","id":"58d8f0721c4d","title":"Composite TyG-lipide-indexen voorspellen incident beroerte beter dan standaardlipiden — CHARLS-cohort","url":"https://hartvaat.nl/2026/10/01/composite-tyg-lipide-indexen-voorspellen-incident-beroerte-beter-dan-standaardli/","new":true},{"updated":"2026-09-18T00:47:15Z","type":"article","id":"515ecf14b9ad","title":"Statinen verlagen LDL-C in de dagpraktijk, maar richtlijntargets blijven vaak onbereikt","url":"https://hartvaat.nl/2026/12/01/statinen-verlagen-ldl-c-in-de-dagpraktijk-maar-richtlijntargets-blijven-vaak-onb/","new":true},{"updated":"2026-09-16T04:17:08Z","type":"podcastepisode","id":"77378","title":"#50: PTSS: hoe een trauma je hersenen & vaten kan afremmen","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-09-16T04:17:07Z","type":"podcastepisode","id":"77377","title":"Journal editorial: Screening for coronary artery disease in hypertensive patients: targeting symptomatic men or asymptomatic women?—when registry results challenge guidelines","url":"https://hartvaat.nl/podcasts/","new":true},{"updated":"2026-09-16T01:36:43Z","type":"article","id":"73cdca8f6ace","title":"Nieuwe VA/DoD-richtlijn lipidenmanagement: Lp(a)-screening, CAC-scans en intensievere statinatherapie","url":"https://hartvaat.nl/2026/09/15/nieuwe-va-dod-richtlijn-lipidenmanagement-lp-a-screening-cac-scans-en-intensieve/","new":true},{"updated":"2026-09-16T01:31:11Z","type":"article","id":"2350d440f08b","title":"Schakelen naar ARNI verlaagt risico op nieuw atriumfibrilleren bij HFrEF","url":"https://hartvaat.nl/2026/09/15/schakelen-naar-arni-verlaagt-risico-op-nieuw-atriumfibrilleren-bij-hfref/","new":true},{"updated":"2026-09-16T01:26:24Z","type":"article","id":"111deb9047bf","title":"Verlaagde spierkracht en balans correleren met hoger NT-proBNP bij CKD-patiënten","url":"https://hartvaat.nl/2026/09/15/verlaagde-spierkracht-en-balans-correleren-met-hoger-nt-probnp-bij-ckd-patienten/","new":true},{"updated":"2026-09-16T01:18:49Z","type":"article","id":"1cc7db276735","title":"Machine learningmodel voor hypertensiescreening heeft lage positief voorspellende waarde","url":"https://hartvaat.nl/2026/09/15/machine-learningmodel-voor-hypertensiescreening-heeft-lage-positief-voorspellend/","new":true},{"updated":"2026-09-16T01:11:52Z","type":"article","id":"e75a901a13f9","title":"Routine preprocedurale data voorspelt linkerventrikelherstel na TAVR en identificeert cardiorenal fenotype","url":"https://hartvaat.nl/2026/10/01/routine-preprocedurale-data-voorspelt-linkerventrikelherstel-na-tavr-en-identifi/","new":true},{"updated":"2026-09-16T01:05:42Z","type":"article","id":"f7672f587476","title":"Rotatiesturing van de aorta ascendens verbetert commissuuralignatie bij Navitor-TAVI","url":"https://hartvaat.nl/2026/10/01/rotatiesturing-van-de-aorta-ascendens-verbetert-commissuuralignatie-bij-navitor-/","new":true},{"updated":"2026-09-16T01:03:04Z","type":"article","id":"f99f9240c512","title":"Klinische oordeelvoeging identificeert hoger MACE-risico ondanks lage HEART-score bij borstpijn","url":"https://hartvaat.nl/2026/10/01/klinische-oordeelvoeging-identificeert-hoger-mace-risico-ondanks-lage-heart-scor/","new":true},{"updated":"2026-09-16T00:59:02Z","type":"article","id":"5d62689ad9b7","title":"GDF-15 correleert met eetlustverlies, spierafbraak en nierdeterioratie bij chronische nierziekte","url":"https://hartvaat.nl/2026/10/01/gdf-15-correleert-met-eetlustverlies-spierafbraak-en-nierdeterioratie-bij-chroni/","new":true},{"updated":"2026-09-16T00:53:23Z","type":"article","id":"55305eb950ef","title":"Barrières in de post-stroke nazorg door huisartsen in een gefragmenteerd zorgsysteem","url":"https://hartvaat.nl/2026/12/01/barrieres-in-de-post-stroke-nazorg-door-huisartsen-in-een-gefragmenteerd-zorgsys/","new":true},{"updated":"2026-09-16T00:47:55Z","type":"article","id":"b9479a085d86","title":"Obesitas en diabetes stijgen, maar CKD-prevalentie blijft stabiel — 20-jaar NHANES-analyse","url":"https://hartvaat.nl/2026/12/01/obesitas-en-diabetes-stijgen-maar-ckd-prevalentie-blijft-stabiel-20-jaar-nhanes-/","new":true},{"updated":"2026-09-14T03:37:48Z","type":"vacancy","id":"890ac07a31f9","title":"Dialyseverpleegkundige","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-14T03:37:47Z","type":"vacancy","id":"be58178e33e0","title":"Verpleegkundige Cardiologie","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-14T03:37:46Z","type":"vacancy","id":"549865094292","title":"Vacature — Dialyseverpleegkundige in opleiding","url":"https://hartvaat.nl/vacatures/","new":false},{"updated":"2026-09-14T03:37:45Z","type":"vacancy","id":"595540c32e1e","title":"Verpleegkundige Vaatchirurgie - Amphia","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-14T03:37:44Z","type":"vacancy","id":"ac720dc4679e","title":"Cardioanesthesioloog - Amphia","url":"https://hartvaat.nl/vacatures/","new":true},{"updated":"2026-09-14T01:25:25Z","type":"article","id":"538835e979aa","title":"Ultrarapid outpatient pad verkort verblijfsduur voor urgente TAVI bij acute aortastenose","url":"https://hartvaat.nl/2026/09/12/ultrarapid-outpatient-pad-verkort-verblijfsduur-voor-urgente-tavi-bij-acute-aort/","new":true},{"updated":"2026-09-14T01:21:20Z","type":"article","id":"dccab1782793","title":"HFpEF-risicoscore ontwikkeld voor primaire zorg met hoge HIV-prevalentie","url":"https://hartvaat.nl/2026/09/12/hfpef-risicoscore-ontwikkeld-voor-primaire-zorg-met-hoge-hiv-prevalentie/","new":true},{"updated":"2026-09-14T01:17:40Z","type":"article","id":"f92c2e383823","title":"Machine learning-algoritmen verbeteren CV-risicoschatting, maar klinische meerwaarde en overdiagnoserisico blijven onbeantwoord","url":"https://hartvaat.nl/2026/09/12/machine-learning-algoritmen-verbeteren-cv-risicoschatting-maar-klinische-meerwaa/","new":true},{"updated":"2026-09-14T01:14:50Z","type":"article","id":"eb536ba82cfa","title":"Ambulant TAVI-pad verkort hospitalisatieduur bij ernstige aortaklepstenose","url":"https://hartvaat.nl/2026/09/12/ambulant-tavi-pad-verkort-hospitalisatieduur-bij-ernstige-aortaklepstenose/","new":true},{"updated":"2026-09-14T01:09:39Z","type":"article","id":"c25d977f3026","title":"Nieuwe atriumfibrillatie na PFO-sluiting komt bij 1 op 9 voor — retrospectieve cohortstudie","url":"https://hartvaat.nl/2026/09/12/nieuwe-atriumfibrillatie-na-pfo-sluiting-komt-bij-1-op-9-voor-retrospectieve-coh/","new":true},{"updated":"2026-09-14T01:06:12Z","type":"article","id":"46060f374cf7","title":"Strakkere bloeddrukcontrole en telemonitoring verbeteren uitkomsten na zwangerschaps-hypertensie","url":"https://hartvaat.nl/2026/09/12/strakkere-bloeddrukcontrole-en-telemonitoring-verbeteren-uitkomsten-na-zwangersc/","new":true},{"updated":"2026-09-14T01:03:01Z","type":"article","id":"7dd6937122e0","title":"Verhoogde TyG-index correleert met cardiovasculaire complicaties bij SLE","url":"https://hartvaat.nl/2026/09/12/verhoogde-tyg-index-correleert-met-cardiovasculaire-complicaties-bij-sle/","new":true},{"updated":"2026-09-14T00:59:09Z","type":"article","id":"0f61e3cff322","title":"SGLT2-remmers: van nierfysiologie naar cardiorenale bescherming","url":"https://hartvaat.nl/2026/09/13/sglt2-remmers-van-nierfysiologie-naar-cardiorenale-bescherming/","new":true},{"updated":"2026-09-14T00:50:01Z","type":"article","id":"01c1b9ea3198","title":"Plasma-extracellulaire vesicles onthullen trombo-inflammatoire pathway bij hypertrofische cardiomyopathie","url":"https://hartvaat.nl/2026/09/18/plasma-extracellulaire-vesicles-onthullen-trombo-inflammatoire-pathway-bij-hyper/","new":true},{"updated":"2026-09-14T00:46:31Z","type":"article","id":"aa752423d734","title":"In-hospital AMI bij obesitas tijdens TAVR komt even vaak voor als bij niet-obese patiënten","url":"https://hartvaat.nl/2026/10/01/in-hospital-ami-bij-obesitas-tijdens-tavr-komt-even-vaak-voor-als-bij-niet-obese/","new":true},{"updated":"2026-09-12T01:20:58Z","type":"article","id":"7ed55e057385","title":"Hoge preoperatieve SII en AIP-waarden correleren met vroege post-CABG complicaties","url":"https://hartvaat.nl/2026/09/11/hoge-preoperatieve-sii-en-aip-waarden-correleren-met-vroege-post-cabg-complicati/","new":true},{"updated":"2026-09-12T01:14:17Z","type":"article","id":"581ce2c4cc68","title":"Catheterablatie biedt geen verbeterde levenskwaliteit boven schijnprocedure bij symptoomrijk atriumfibrilleren — PVI-SHAM-AF","url":"https://hartvaat.nl/2026/09/12/catheterablatie-biedt-geen-verbeterde-levenskwaliteit-boven-schijnprocedure-bij-/","new":true},{"updated":"2026-09-12T01:10:13Z","type":"article","id":"975446a3024d","title":"Gestandaardiseerde echografie voor rechterhart en longembolie — Chinese expertconsensus 2026","url":"https://hartvaat.nl/2026/09/12/gestandaardiseerde-echografie-voor-rechterhart-en-longembolie-chinese-expertcons/","new":true},{"updated":"2026-09-12T01:07:07Z","type":"article","id":"a409033fe6b9","title":"Cardiale en neurologische betrokkenheid bij ATTR-amyloïdose — overzicht","url":"https://hartvaat.nl/2026/10/01/cardiale-en-neurologische-betrokkenheid-bij-attr-amyloidose-overzicht/","new":true},{"updated":"2026-09-12T01:04:28Z","type":"article","id":"f09e195bafc3","title":"Vroege herkenning van Fabryziekte voorkomt hartfalen en neurologische complicaties","url":"https://hartvaat.nl/2026/10/01/vroege-herkenning-van-fabryziekte-voorkomt-hartfalen-en-neurologische-complicati/","new":true},{"updated":"2026-09-12T01:01:33Z","type":"article","id":"dd1de0a5af47","title":"Deep-learningmodel detecteert hypertrofische cardiomyopathie met point-of-care echocardiografie","url":"https://hartvaat.nl/2026/10/01/deep-learningmodel-detecteert-hypertrofische-cardiomyopathie-met-point-of-care-e/","new":true},{"updated":"2026-09-12T00:58:15Z","type":"article","id":"b2dbbbca2b8e","title":"PFO-sluiting bij cryptogene beroerte: selectie, timing en antithrombotische strategie","url":"https://hartvaat.nl/2026/10/01/pfo-sluiting-bij-cryptogene-beroerte-selectie-timing-en-antithrombotische-strate/","new":true},{"updated":"2026-09-12T00:55:12Z","type":"article","id":"2add356a3f15","title":"Neurogenieke hart syndromen: hersenen-hartas en praktische classificatie","url":"https://hartvaat.nl/2026/10/01/neurogenieke-hart-syndromen-hersenen-hartas-en-praktische-classificatie/","new":true},{"updated":"2026-09-12T00:51:42Z","type":"article","id":"67fac1b2d432","title":"Samenhang tussen hartfalen en embolie: diagnostiek en anticoagulatie bij atriale cardiomyopathie","url":"https://hartvaat.nl/2026/10/01/samenhang-tussen-hartfalen-en-embolie-diagnostiek-en-anticoagulatie-bij-atriale-/","new":true},{"updated":"2026-09-12T00:48:10Z","type":"article","id":"5cd0145d7434","title":"Richtlijntherapie hartfalen blijft onderbenut bij patiënten met HIV","url":"https://hartvaat.nl/2026/12/31/richtlijntherapie-hartfalen-blijft-onderbenut-bij-patienten-met-hiv/","new":true},{"updated":"2026-09-10T01:22:30Z","type":"article","id":"8ccc0d7c84f0","title":"Combinatie van CAC-score, volume en dichtheid verbetert risicoschatting","url":"https://hartvaat.nl/2026/09/09/combinatie-van-cac-score-volume-en-dichtheid-verbetert-risicoschatting/","new":true},{"updated":"2026-09-10T01:17:09Z","type":"article","id":"b107e02052f5","title":"Finerenone verlaagt cardiorenale uitkomsten bij diabetische nierziekte — FIDELITY-samenvoeging","url":"https://hartvaat.nl/2026/09/09/finerenone-verlaagt-cardiorenale-uitkomsten-bij-diabetische-nierziekte-fidelity-/","new":true},{"updated":"2026-09-10T01:09:17Z","type":"article","id":"78ad3f318474","title":"Tolvaptan bij hartfalen: conceptueel kader voor gerichte decongestie","url":"https://hartvaat.nl/2026/09/09/tolvaptan-bij-hartfalen-conceptueel-kader-voor-gerichte-decongestie/","new":true},{"updated":"2026-09-10T01:06:09Z","type":"article","id":"603259a379de","title":"Gepromptte sms-berichten verhogen betrokkenheid bij remote monitoring bij hartfalen — geen klinisch voordeel","url":"https://hartvaat.nl/2026/09/09/gepromptte-sms-berichten-verhogen-betrokkenheid-bij-remote-monitoring-bij-hartfa/","new":true},{"updated":"2026-09-10T01:00:32Z","type":"article","id":"d48f0b54318b","title":"Semaglutide verbetert enkele endotheelmarkers bij diabetes type 2 — post-hoc analyse","url":"https://hartvaat.nl/2026/10/01/semaglutide-verbetert-enkele-endotheelmarkers-bij-diabetes-type-2-post-hoc-analy/","new":true},{"updated":"2026-09-10T00:56:54Z","type":"article","id":"eadfa0f2d32b","title":"Hartfalenprevalentie en -progressie bij type-2-diabetes in hoog risicokader — HF-LANDMARK","url":"https://hartvaat.nl/2026/10/01/hartfalenprevalentie-en-progressie-bij-type-2-diabetes-in-hoog-risicokader-hf-la/","new":true},{"updated":"2026-09-10T00:53:44Z","type":"article","id":"e8946b68e69e","title":"Gecombineerde indices van ontsteking, triglyceriden en glucose correleren met sterfte bij afwijkende glycemiestatus","url":"https://hartvaat.nl/2026/10/01/gecombineerde-indices-van-ontsteking-triglyceriden-en-glucose-correleren-met-ste/","new":true},{"updated":"2026-09-10T00:49:32Z","type":"article","id":"9fc2607405f6","title":"pLAAO en S-LAAO reduceren trombo-embolisch risico bij niet-valvulair AF — narratieve review","url":"https://hartvaat.nl/2026/11/01/plaao-en-s-laao-reduceren-trombo-embolisch-risico-bij-niet-valvulair-af-narratie/","new":true},{"updated":"2026-09-10T00:46:03Z","type":"article","id":"11a704071d78","title":"Anticoagulatie bij apparaatgedetecteerde atriumfibrilleren: afwegen van netoclinisch voordeel","url":"https://hartvaat.nl/2026/11/01/anticoagulatie-bij-apparaatgedetecteerde-atriumfibrilleren-afwegen-van-netoclini/","new":true},{"updated":"2026-09-09T04:17:07Z","type":"podcastepisode","id":"76137","title":"#49: Hoteldebotel & vlinders in je buik: is verliefdheid gezond?","url":"https://hartvaat.nl/podcasts/","new":true}]}